Citation tools
"Bendamustin–Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the Literature." Anticancer Research
36.6
(2016):
2827-2838.
Web. 18 April. 2024.